Microbiome, Metagenomics & Host-Microbe Interactions
Session Overview
The human microbiome represents a complex ecosystem that profoundly influences physiology, disease susceptibility, and therapeutic response. This session explores the frontier of metagenomic science, moving beyond cataloging microbial inhabitants to understanding their functional interplay with the host. We will examine how advanced sequencing and bioinformatic tools are decoding the microbiome’s role in health, its contribution to chronic diseases, and its potential as a target for novel diagnostic and therapeutic strategies, thereby integrating microbial ecology into the framework of personalized medicine.
Why This Session Matters Now
Research into host-microbe interactions is transitioning from associative studies to mechanistic and translational investigations. The microbiome is increasingly recognized as a key modifier of individual health, affecting metabolism, immunity, and even neurology. This session addresses the critical need to synthesize insights from microbial ecology, immunology, genomics, and clinical medicine. As microbiome-based diagnostics and interventions enter clinical consideration, understanding the underlying science, methodological rigor, and therapeutic potential is essential for researchers and clinicians alike.
Key Scientific and Clinical Themes
Gut microbiome composition and health outcomes
Investigating the links between the structure and diversity of the gut microbial community and a broad range of health states, from homeostasis to disease.
Microbiome in metabolic and immune conditions
Exploring the mechanistic role of the microbiome in the pathogenesis and progression of complex conditions such as obesity, diabetes, inflammatory bowel disease, and autoimmune disorders.
Microbial diagnostics and metagenomic methodologies
Discussing the evolution of sequencing-based and functional assays for microbiome analysis, including shotgun metagenomics, metatranscriptomics, and standardized protocols for robust biomarker discovery.
Pharmacomicrobiomics and drug-microbiome interactions
Examining the bidirectional relationship where the microbiome modulates drug metabolism and efficacy, and where drugs, in turn, alter microbial communities, with implications for personalized dosing and adverse effects.
Microbiome-host immune system interactions
Delving into the molecular dialogue between microbes and the host immune system, focusing on how microbial signals educate immunity, maintain barrier function, and can contribute to inflammatory or tolerogenic states.
FMT and microbiome-based therapeutics
Assessing the current evidence, mechanisms, and future directions for fecal microbiota transplantation and other live biotherapeutic products for treating recurrent infections and other dysbiosis-related conditions.
Probiotic personalization and precision nutrition
Evaluating the scientific basis for targeting the microbiome through diet, prebiotics, and next-generation probiotics, with a focus on moving beyond generic approaches to strategies personalized to an individual’s microbial and metabolic profile.
Nature of Research in This Field
Microbiome research is fundamentally interdisciplinary, integrating microbiology, genomics, bioinformatics, immunology, and clinical science. The field is characterized by a shift from 16S rRNA gene surveys to functional multi-omic profiling (metagenomics, metatranscriptomics, metabolomics) to move from correlation to causation. A major focus is on establishing causal links through sophisticated experimental models, including gnotobiotic animals and in vitro systems. Research spans foundational microbial ecology, translational clinical trials, and the development of data science tools to manage and interpret highly complex, multidimensional datasets.
Who Should Attend
This session is designed for:
- Microbiologists, microbial ecologists, and metagenomic scientists.
- Gastroenterologists, immunologists, endocrinologists, and nutritionists.
- Bioinformatics specialists working with complex microbial datasets.
- Researchers in infectious diseases, chronic inflammation, and metabolomics.
- Clinical trialists and translational scientists developing microbiome-based therapies.
- Professionals in the food, supplement, and biotherapeutic industries.
- Public health researchers interested in the environmental and dietary determinants of health.
Session Perspective
“Microbiome, Metagenomics & Host-Microbe Interactions” reframes the human as a holistic meta-organism. This session emphasizes that human health cannot be fully understood by examining the human genome alone; it requires an integrated view of our associated microbial genomes. By exploring the pathways of communication and influence between host and microbiota, this session seeks to illuminate how this symbiotic relationship shapes well-being and disease, guiding the responsible development of microbiome-informed science for diagnosis, prevention, and treatment.
If your research aligns with this session, we invite you to submit an abstract for consideration.
